Adipose-derived stem cells (ADSCs) are stem cells originated from adipocytes. ADSCs have characteristics similar to bone marrow mesenchymal stem cells. Thus Adipose-derived stem cells substitute for bone marrow as a source of stem cells. Different varieties of manual and automatic stem cell separation procedures are used to separate adipose stem cells (ASCs) from adipose tissue. Flow cytometry can be utilized to isolate ADSCs from other stem cells within a cell solution. Currently, adipose derived stem cells (ADSCs) are generally used in the generation of regenerative medicine due to its anti-inflammatory, anti-apoptotic, and immunomodulatory properties.
MARKET DYNAMICS
The Adipose Derived Stem Cell Therapy Market is growing due to increasing use of regenerative medicine in disease treatment and increasing private and public funding for stem cell therapy. However, high cost associated with stem cell processing hampers growth of this market.
MARKET SCOPE
The "Adipose Derived Stem Cell Therapy Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Adipose Derived Stem Cell Therapy market with detailed market segmentation cell type, product, disease and end user. The Adipose Derived Stem Cell Therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Adipose Derived Stem Cell Therapy Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Adipose Derived Stem Cell Therapy market is segmented on the basis of cell type, product, disease and end user. Based on cell type, the market is segmented as autologous stem cells, allogeneic stem cells. On the basis of product, the market is categorized as cell line and culture media. Based on disease the market is segmented into cancer, obesity, wounds and injuries, musculoskeletal diseases, cardiovascular diseases and others. Based on end user the market is segmented into hospitals and trauma centers , cell banks and tissue banks , research laboratories and academic institutes and other
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Adipose Derived Stem Cell Therapy Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Adipose Derived Stem Cell Therapy Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Adipose Derived Stem Cell Therapy Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Adipose Derived Stem Cell Therapy Market in these regions.
MARKET PLAYERS
The report covers key developments in the Adipose Derived Stem Cell Therapy Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Adipose Derived Stem Cell Therapy Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Adipose Derived Stem Cell Therapy Market in the global market. Below mentioned is the list of few companies engaged in the Adipose Derived Stem Cell Therapy Market.
The report also includes the profiles of key players in Adipose Derived Stem Cell Therapy Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AlloCure, Inc
- Antria, Inc.
- Celgene Corporation
- Cellleris SA
- Corestem, Inc.
- Cytori Therapeutics, LLC
- Intrexon, Inc.
- Mesoblast Ltd.
- Pluristem Therapeutics, Inc.
- Tissue Genesis, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.